{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:17:46Z","timestamp":1792451866043,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.jaut.2020.102402","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T18:15:53Z","timestamp":1579630553000},"page":"102402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves\u2019 disease"],"prefix":"10.1016","volume":"108","author":[{"given":"Cheuk Wun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Menconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlinda","family":"Concepcion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2020.102402_bib1","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical review: clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1568-9972(01)00016-7","article-title":"Iodine: an environmental trigger of thyroiditis","volume":"1","author":"Rose","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2020.102402_bib3","first-page":"107","article-title":"Infection, thyroid disease, and autoimmunity","volume":"14","author":"Tomer","year":"1993","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2020.102402_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1210\/er.2002-0030","article-title":"Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function","volume":"24","author":"Tomer","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2020.102402_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.gene.6364059","article-title":"Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease","volume":"5","author":"Ban","year":"2004","journal-title":"Genes Immun."},{"key":"10.1016\/j.jaut.2020.102402_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/edrv-10-4-537","article-title":"The causes of autoimmune thyroid disease","volume":"10","author":"DeGroot","year":"1989","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2020.102402_bib7","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1073\/pnas.0806584105","article-title":"Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice","volume":"105","author":"Menconi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2020.102402_bib8","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1074\/jbc.271.8.4545","article-title":"Shedding of human thyrotropin receptor ectodomain. Involvement of a matrix metalloprotease","volume":"271","author":"Couet","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2020.102402_bib9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI200317069","article-title":"The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim","volume":"111","author":"Chen","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2020.102402_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0303-7207(93)90077-W","article-title":"Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease","volume":"92","author":"Sakata","year":"1993","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jaut.2020.102402_bib11","first-page":"3361","article-title":"Detection of major T cell epitopes on human thyroid stimulating hormone receptor by overriding immune heterogeneity in patients with Graves' disease","volume":"82","author":"Martin","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib12","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1089\/thy.2008.0349","article-title":"Immune response of mice transgenic for human histocompatibility leukocyte Antigen-DR to human thyrotropin receptor-extracellular domain","volume":"19","author":"Inaba","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2020.102402_bib13","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2009-2393","article-title":"The role of glutamic or aspartic acid in position four of the epitope binding motif and thyrotropin receptor-extracellular domain epitope selection in Graves' disease","volume":"95","author":"Inaba","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib14","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1210\/en.2013-1033","article-title":"Epitope recognition in HLA-DR3 transgenic mice immunized to TSH-R protein or peptides","volume":"154","author":"Inaba","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2020.102402_bib15","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1210\/jc.2005-2537","article-title":"Thyrotropin receptor epitopes and their relation to histocompatibility leukocyte antigen-DR molecules in Graves' disease","volume":"91","author":"Inaba","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib16","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/thy.2006.16.1221","article-title":"HLA-DR3 transgenic mice immunized with adenovirus encoding the thyrotropin receptor: T cell epitopes and functional analysis of the CD40 Graves' polymorphism","volume":"16","author":"Pichurin","year":"2006","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2020.102402_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/thy.1994.4.37","article-title":"Proliferative responses of peripheral blood mononuclear cells from patients with Graves' disease to synthetic peptides epitopes of human thyrotropin receptor","volume":"4","author":"Okamoto","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2020.102402_bib18","first-page":"905","article-title":"T-cells recognize multiple epitopes in the human thyrotropin receptor extracellular domain","volume":"80","author":"Soliman","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/thy.1996.6.545","article-title":"T-cell recognition of residue 158-176 in thyrotropin receptor confers risk for development of thyroid autoimmunity in siblings in a family with Graves' disease","volume":"6","author":"Soliman","year":"1996","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2020.102402_bib20","first-page":"3655","article-title":"Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease","volume":"82","author":"Fisfalen","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib21","first-page":"1176","article-title":"Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule","volume":"85","author":"Sawai","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib22","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1210\/endo.136.10.7664661","article-title":"Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading","volume":"136","author":"Vlase","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2020.102402_bib23","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1074\/jbc.M115.694687","article-title":"Identifying a small molecule blocking antigen presentation in autoimmune thyroiditis","volume":"291","author":"Li","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jaut.2020.102402_bib24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00251-015-0873-y","article-title":"Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification","volume":"67","author":"Andreatta","year":"2015","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jaut.2020.102402_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.09.007","article-title":"Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes","volume":"76","author":"Li","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jaut.2020.102402_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0198-8859(94)90268-2","article-title":"HLA-DR alpha chain residues located on the outer loops are involved in nonpolymorphic and polymorphic antibody-binding epitopes","volume":"39","author":"Fu","year":"1994","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.jaut.2020.102402_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/105072503321582024","article-title":"A major role for non-major histocompatibility complex genes but not for microorganisms in a novel murine model of Graves' hyperthyroidism","volume":"13","author":"Nagayama","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2020.102402_bib28","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4049\/jimmunol.168.6.2789","article-title":"A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor","volume":"168","author":"Nagayama","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102402_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1210\/en.2003-1134","article-title":"Low-dose immunization with adenovirus expressing the thyroid-stimulating hormone receptor A-subunit deviates the antibody response toward that of autoantibodies in human Graves' disease","volume":"145","author":"Chen","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaut.2020.102402_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fendo.2016.00003","article-title":"The \u201cTSH receptor glo assay\u201d - a high-throughput detection system for thyroid stimulation","volume":"7","author":"Latif","year":"2016","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.jaut.2020.102402_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/378457a0","article-title":"The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3","volume":"378","author":"Ghosh","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2020.102402_bib32","series-title":"AMBER","author":"Case","year":"2018"},{"key":"10.1016\/j.jaut.2020.102402_bib33","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jaut.2020.102402_bib34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2014.03.047","article-title":"Deconstructing the peptide-MHC specificity of T cell recognition","volume":"157","author":"Birnbaum","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2020.102402_bib35","first-page":"673","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2020.102402_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1210\/er.2015-1098.2016.1","article-title":"TSH receptor cleavage into subunits and shedding of the A-subunit; A molecular and clinical perspective","volume":"2016","author":"Rapoport","year":"2016","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jaut.2020.102402_bib37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1210\/jc.2008-2134","article-title":"Evidence that shed thyrotropin receptor A subunits drive affinity maturation of autoantibodies causing Graves' disease","volume":"94","author":"Mizutori","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2020.102402_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044669","article-title":"Antibody protection reveals extended epitopes on the human TSH receptor","volume":"7","author":"Latif","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2020.102402_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/thy.2007.0034","article-title":"Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody","volume":"17","author":"Sanders","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.jaut.2020.102402_bib40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1086\/426947","article-title":"Regression mapping of association between the human leukocyte antigen region and Graves disease","volume":"76","author":"Simmonds","year":"2005","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jaut.2020.102402_bib41","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI31368","article-title":"Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity","volume":"117","author":"Nakayama","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2020.102402_bib42","doi-asserted-by":"crossref","first-page":"9724","DOI":"10.1073\/pnas.85.24.9724","article-title":"Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1","volume":"85","author":"Teitelbaum","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2020.102402_bib43","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1021\/jm030362s","article-title":"Structure-based discovery of nonpeptidic small organic compounds to block the T cell response to myelin basic protein","volume":"47","author":"Koehler","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jaut.2020.102402_bib44","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.4049\/jimmunol.1300407","article-title":"Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis","volume":"191","author":"Ji","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102402_bib45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/ci100444c","article-title":"Identification of small-molecule inhibitors against human leukocyte antigen-death receptor 4 (HLA-DR4) through a comprehensive strategy","volume":"51","author":"Liu","year":"2011","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jaut.2020.102402_bib46","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.4049\/jimmunol.1100746","article-title":"Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation","volume":"187","author":"Michels","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2020.102402_bib47","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1172\/JCI97739","article-title":"Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes","volume":"128","author":"Ostrov","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.jaut.2020.102402_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1734-1140(11)70500-X","article-title":"Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions","volume":"63","author":"Rogosnitzky","year":"2011","journal-title":"Pharmacol. Rep. : PR"},{"key":"10.1016\/j.jaut.2020.102402_bib49","first-page":"471","article-title":"[Effect of cepharanthin on radiotherapy induced leukopenia]","volume":"35","author":"Ohta","year":"1990","journal-title":"Rinsho hoshasen Clin. radiogr."},{"key":"10.1016\/j.jaut.2020.102402_bib50","first-page":"2587","article-title":"Clinical effects of cepharanthin (Ceph.) on leukopenia by chemotherapy in lung cancer patients","volume":"24","author":"Saito","year":"1989","journal-title":"Nihon Gan Chiryo Gakkai-Shi"},{"key":"10.1016\/j.jaut.2020.102402_bib51","first-page":"647","article-title":"[Effects of cepharanthin on leukopenia and thrombocytopenia induced by chemotherapy in lung cancer patients]","volume":"19","author":"Suzuki","year":"1992","journal-title":"Gan to kagaku ryoho Cancer chemother."},{"key":"10.1016\/j.jaut.2020.102402_bib52","first-page":"2701","article-title":"[Effects of cepharanthin on leukopenia and thrombocytopenia caused by CDDP-ACR-CPA therapy of ovarian cancer]","volume":"15","author":"Ushiki","year":"1988","journal-title":"Gan to kagaku ryoho Cancer chemother."},{"key":"10.1016\/j.jaut.2020.102402_bib53","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.intimp.2012.04.015","article-title":"Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma","volume":"13","author":"Tabata","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jaut.2020.102402_bib54","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1346-8138.2002.tb00199.x","article-title":"Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies","volume":"29","author":"Morita","year":"2002","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jaut.2020.102402_bib55","first-page":"47","article-title":"[Effect of cepharanthine on alopecia areata]","volume":"64","author":"Niwa","year":"1969","journal-title":"Hifuka kiyo Acta Dermatol."},{"key":"10.1016\/j.jaut.2020.102402_bib56","first-page":"71","article-title":"Therapeutic experience of venomous snakebites by the Japanese viper (Agkistrodon halys Blomhoffii) with low dose of antivenin: report of 43 consecutive cases","volume":"66","author":"Kimoto","year":"1997","journal-title":"Nihon geka hokan Arch. Jpn. Chir."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119306973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841119306973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:25:14Z","timestamp":1760257514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841119306973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":56,"alternative-id":["S0896841119306973"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102402","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves\u2019 disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2020.102402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102402"}}